相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carrier-Free Immunotherapeutic Nano- Booster with Dual Synergistic Effects Based on Glutaminase Inhibition Combined with Photodynamic Therapy
Ziyi Mai et al.
ACS NANO (2023)
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action
Peter Jaein Choi et al.
MOLECULES (2022)
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
Shuyu Zheng et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2022)
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
Amirhossein Mardi et al.
CANCER CELL INTERNATIONAL (2022)
Designing Soluble PROTACs: Strategies and Preliminary Guidelines
Diego Garcia Jimenez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Ce6-and Bez235-Based Nanomedicine for Chemo-/Photodynamic Combination Therapy of Tumors
Fu-An Deng et al.
ACS APPLIED NANO MATERIALS (2022)
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L. Mayer et al.
LANCET ONCOLOGY (2021)
Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors
Roman Uzhachenko et al.
CELL REPORTS (2021)
Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
Baishan Jiang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Selective degradation of CDK6 by a palbociclib based PROTAC
Sandeep Rana et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
Shang Su et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Matthias Brand et al.
CELL CHEMICAL BIOLOGY (2019)
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Jiehui Deng et al.
CANCER DISCOVERY (2018)
Polydopamine Nanoparticles Enhance Drug Release for Combined Photodynamic and Photothermal Therapy
Barbara Poinard et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Functions of the CXC ligand family in the pancreatic tumor microenvironment
Nien-Hung Lee et al.
PANCREATOLOGY (2018)
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
C. Yang et al.
ONCOGENE (2017)
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
H. Zhang et al.
ONCOGENE (2017)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
Palbociclib can overcome mutations in cyclin dependent kinase 6 that break hydrogen bonds between the drug and the protein
Stella Hernandez Maganhi et al.
PROTEIN SCIENCE (2017)
Quantitative Cell Cycle Analysis Based on an Endogenous All-in-One Reporter for Cell Tracking and Classification
Thomas Zerjatke et al.
CELL REPORTS (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies
Wenyue Hu et al.
CLINICAL CANCER RESEARCH (2016)
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Shom Goel et al.
CANCER CELL (2016)
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance
Ping Chen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities
Jorge Franco et al.
CELL REPORTS (2016)
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Subcellular location and photodynamic therapeutic effect of chlorin e6 in the human tongue squamous cell cancer Tca8113 cell line
Wei Luo et al.
ONCOLOGY LETTERS (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
The retinoblastoma protein induces apoptosis directly at the mitochondria
Keren I. Hilgendorf et al.
GENES & DEVELOPMENT (2013)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation
Laurence Bockstaele et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness
Luca Hegedus et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
The Rb/E2F pathway: expanding roles and emerging paradigms
JW Harbour et al.
GENES & DEVELOPMENT (2000)
分享论文
